Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2022

View Archived Issues

Loss of PHGDH potentiates metastatic dissemination

Kymera Therapeutics presents data on the IRAK4 degrader KT-474 in different cell subsets

Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors

Idorsia Pharmaceuticals patents new LGALS3 inhibitors

Follicum AB and University of Bradford disclose compounds for skin and hair disorders

Boehringer Ingelheim Pharma KG identifies new EGFR mutant inhibitors

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

Anti-IL13RA1 eblasakimab reduces neuronal response to proinflammatory cytokines

Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01

Elicio shows AMP vaccination significantly enhances TCR-T antitumor response in tumor model

Quoin enters research agreement with QUT to target VCAM-1:VL-4 interaction to treat scleroderma

Antigen-specific immunotolerance platform shows preclinical proof of concept for Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...